Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

DICLOXACILLIN SODIUM

DICLOXACILLIN SODIUM

Standard Dose
EQ 62.5MG BASE/5ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview DICLOXACILLIN SODIUM is listed in Drugs@FDA under application 061455 (ANDA).

Marketing status: Discontinued Active ingredient DICLOXACILLIN SODIUM Form and strength FOR SUSPENSION;ORAL - EQ 62.5MG BASE/5ML Sponsor APOTHECON Submission history Latest submission status date: 1998-06-30 00:00:00.

Structured Monograph

Clinical summary

Approval overview DICLOXACILLIN SODIUM is listed in Drugs@FDA under application 061455 (ANDA). Marketing status: Discontinued Active ingredient DICLOXACILLIN SODIUM Form and strength FOR SUSPENSION;ORAL - EQ 62.5MG BASE/5ML Sponsor APOTHECON Submission history Latest submission status date: 1998-06-30 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.